BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 31, 2008
View Archived Issues
FDA advisory committee recommends approval of Chugai and Roche's Actemra in RA
Read More
Integrated BioPharma sets record and distribution dates for spin-off of iBioPharma
Read More
[11C]-AFM, a novel PET imaging agent to visualize serotonin transporters
Read More
FDA accepts for filing Meda's registration application for Sublinox
Read More
Zogenix secures financing to launch sumatriptan DosePro
Read More
Chroma Therapeutics' CHR-3996 histone deacetylase inhibitor to be evaluated in a phase I study
Read More
Phase II results of AL-108 for amnestic MCI presented at ICAD meeting
Read More
Novel GSK-3 inhibitor increases neuron survival and attenuates neuropathology in transgenic AD mice
Read More
Millennium presents an update on clinical development
Read More
Pronucleon peptide technology effective for beta amyloid imaging in mice
Read More
Lexicon reports results from phase I study of LX-1031 in IBS
Read More
Inspire modifies clinical protocol for phase III TIGER-2 trial of denufosol tetrasodium in CF
Read More
Intercept completes USD 25 million equity financing
Read More
GSK launches Volibris for pulmonary arterial hypertension in the U.K.
Read More
Ariad initiates phase II clinical trial of deforolimus in breast cancer
Read More
Hollis-Eden initiates phase I/II clinical trial of Apoptone in late-stage prostate cancer
Read More
FDA approves Noven's Stavzor for bipolar disorder, seizures and migraine headaches
Read More
Novel antiinfective agents reported in recent patents
Read More
Idenix presents an update on the company's clinical development plans
Read More
Bristol-Myers Squibb prepares and tests novel factor VIIa inhibitors
Read More
New agents for diagnosis of congestive heart failure described in BMS patent
Read More
ReceptoPharm successfully completes phase IIb/IIIa clinical trial of RPI-78M in AMN
Read More
Regulatory approval of Basilea's Toctino recommended under European decentralized procedure
Read More
Infinity initiates phase I clinical trial of IPI-493 in advanced solid tumors
Read More
Othera submits IND application to FDA for OT-730 in glaucoma
Read More